Shishin Maxim, the chief information officer of CorVel (NASDAQ:CRVL) , reported the exercise and immediate sale of 2,400 shares of common stock for a total transaction value of approximately $130,000 on March 16, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($54.00); post-transaction value based on March 16, 2026 market close ($54.0...
Shishin Maxim, the chief information officer of CorVel (NASDAQ:CRVL) , reported the exercise and immediate sale of 2,400 shares of common stock for a total transaction value of approximately $130,000 on March 16, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($54.00); post-transaction value based on March 16, 2026 market close ($54.00). CorVel Corporation is a leading provider of technology-enabled healthcare management and insurance solutions, with a focus on cost containment and process optimization for claims. The company leverages advanced analytics and automation to deliver efficient, scalable services to a diverse client base. Its strategic emphasis on innovation and operational efficiency supports its competitive position in the insurance services sector. Continue reading
(RTTNews) - The South Korea stock market has climbed higher in back-to-back sessions, gaining almost 240 points or 4.4 percent along the way. The KOSPI now sits just above the 5,640-point plateau and it's tipped to open in the green again on Thursday.
(RTTNews) - The South Korea stock market has climbed higher in back-to-back sessions, gaining almost 240 points or 4.4 percent along the way. The KOSPI now sits just above the 5,640-point plateau and it's tipped to open in the green again on Thursday.
ROCKVILLE, Md. and SUZHOU, China, March 25, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred hereinto as “Ascentage Pharma,” the “Company,” “we,” “us” or “our”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to addres...
ROCKVILLE, Md. and SUZHOU, China, March 25, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred hereinto as “Ascentage Pharma,” the “Company,” “we,” “us” or “our”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, today reported its unaudited financial results for the year ended December 31, 2025, and provided updates on key ongoing clinical programs and commercial activities.
INVESTOR NOTICE: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces Business Wire
INVESTOR NOTICE: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces Business Wire
Explore the exciting world of Tetra Tech (NASDAQ: TTEK) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities! *Stock prices used were the prices of Feb. 4, 2026. The video was published on March 25, 2026. Continue reading
Explore the exciting world of Tetra Tech (NASDAQ: TTEK) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities! *Stock prices used were the prices of Feb. 4, 2026. The video was published on March 25, 2026. Continue reading
INVESTOR NOTICE: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces Carroll County Mirror-Democrat
INVESTOR NOTICE: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces Carroll County Mirror-Democrat
INVESTOR NOTICE: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces mydailyrecord.com
INVESTOR NOTICE: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces mydailyrecord.com
INVESTOR NOTICE: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces The Norfolk Daily News
INVESTOR NOTICE: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces The Norfolk Daily News
INVESTOR NOTICE: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces businesswire.com
INVESTOR NOTICE: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces businesswire.com
Latest strike brings number of deaths to at least 163 since attacks on alleged ‘narco-terrorists’ began in September The US has launched another strike on a vessel in the Caribbean, killing four people, the US Southern Command said. The command which oversees combatant operations in Latin America and the Caribbean announced on X that it had conducted a “lethal kinetic strike on a vessel operated b...
Latest strike brings number of deaths to at least 163 since attacks on alleged ‘narco-terrorists’ began in September The US has launched another strike on a vessel in the Caribbean, killing four people, the US Southern Command said. The command which oversees combatant operations in Latin America and the Caribbean announced on X that it had conducted a “lethal kinetic strike on a vessel operated by Designated Terrorist Organizations”. Continue reading...
Earnings Call Insights: Precigen, Inc. (PGEN) Q4 2025 Management View Helen Sabzevari, President and CEO, highlighted the company's transformation to a "product revenue-generating commercial biotech company" following the full FDA approval and commercial launch of PAPZIMEOS, the first therapeutic for adult recurrent respiratory papillomatosis (RRP). She reported, "net product revenue for Q4 2025 w...
Earnings Call Insights: Precigen, Inc. (PGEN) Q4 2025 Management View Helen Sabzevari, President and CEO, highlighted the company's transformation to a "product revenue-generating commercial biotech company" following the full FDA approval and commercial launch of PAPZIMEOS, the first therapeutic for adult recurrent respiratory papillomatosis (RRP). She reported, "net product revenue for Q4 2025 was $3.4 million, with shipments commencing in November" and stated, "we expect revenues in Q1 to exceed $18 million." Sabzevari emphasized PAPZIMEOS' "broad label for adult RRP with no restriction based on the number of prior surgeries" and underscored its "unmatched efficacy" and "durable ongoing responses," citing more than three years of follow-up in clinical studies. She noted a consensus paper published by 16 leading U.S. physicians recommending PAPZIMEOS as the "preferred first-line treatment for adults with recurrent respiratory papillomatosis." Phil Tennant, Chief Commercial Officer, described the rapid expansion of payer coverage, stating, "In early January, we had approximately 170 million lives covered, which has now increased to approximately 215 million, including nearly all major payers across commercial, Medicare and Medicaid." Tennant reported over 300 patients in the Precigen patient support hub and observed, "Brand utilization is accelerating across the country in both the large institutions and academic centers as well as in the community setting." Harry Thomasian, Chief Financial Officer, stated, "Revenue for the year totaled $9.7 million versus $3.9 million in 2024, resulting in an increase of $5.8 million or 149%." He added, "We expect revenue for Q1 of 2026 will exceed $18 million." Thomasian also noted, "Our net loss attributable to common shareholders was $429.6 million, or $1.37 per share for the year ended December 31, 2025," with two large noncash items totaling $318.5 million or $1.02 per share, which "will not recur in the future." Sabzevari an...
Lima The Environmental Protection Agency issued a temporary waiver Wednesday to allow the nationwide sale of E15 ethanol gasoline, as part of an effort to maintain domestic supplies and ease prices at the gasoline pump that have surged because of war in the Middle East. The waiver, which takes effect for 20 days starting May 1 and can be extended if needed, will allow retailers to sell less expen...
Lima The Environmental Protection Agency issued a temporary waiver Wednesday to allow the nationwide sale of E15 ethanol gasoline, as part of an effort to maintain domestic supplies and ease prices at the gasoline pump that have surged because of war in the Middle East. The waiver, which takes effect for 20 days starting May 1 and can be extended if needed, will allow retailers to sell less expensive formulations of gasoline, including mixtures that include 15% ethanol, that are typically not permitted during warmer months. The EPA's action also will remove all federal impediments to selling E10—gasoline blended with 10% ethanol—across the country, including in a group of seven Midwestern states that would have otherwise required that blend to be mixed with less volatile but costlier blendstocks . Analysts said the moves could trim several cents per gallon off retail prices; the U.S. average price for regular gasoline is running just over $3.98/gal, up more than a dollar from a month ago, according to AAA. "We foresee potential for a disruption to the American fuel supply," EPA Administrator Zeldin said at a press conference at the CERAWeek energy conference in Houston, where the waiver was announced. Potential relevant stocks include Valero Energy ( VLO ), Marathon Petroleum ( MPC ), Phillips 66 ( PSX ), HF Sinclair ( DINO ), PBF Energy ( PBF ), Delek US ( DK ), Archer Daniels Midland ( ADM ), Bunge ( BG ), Green Plains ( GPRE ), Gevo ( GEVO ), Clean Energy Fuels ( CLNE ), REX American Resources ( REX ), Darling Ingredients ( DAR ), FutureFuel ( FF ). ETF: ( CRAK ) More on Valero Energy and Archer Daniels Midland Valero Is Much More Than Fossil Based Crack Spreads Valero Energy: Still Pumping Cash, But The Valuation Looks Bloated Archer Daniels Midland: Policy Wins Don't Fix This Dividend King's Valuation